JAMDA
October 25, 2019
Showing 41 - 50 of 2516 results
JAMDA
February 25, 2016
Reduction of Falls in Nursing Home by Improvement in Fall Assessment Accuracy and Early Nursing Interventions Leading to Improved Quality of Life and Substantial Cost Reduction and Improved Quality of Life
JAMDA
August 9, 2018
Discontinuation of Long-Term Antipsychotic Drug Use for Behavioral and Psychological Symptoms in Older Adults Aged 65 Years and Older With Dementia
Antipsychotic drugs are often used to treat behavioral and psychological symptoms (BPSD) in adults aged 65 years and older with dementia, although there is uncertainty about the effectiveness of long-term use for this indication and there are concerns that they may cause harm.
JAMDA
September 24, 2014
Use of Antipsychotic Drugs Among Residents With Dementia in European Long-Term Care Facilities: Results From the SHELTER Study
Behavioral and psychological symptoms of dementia (BPSD) are common reasons for use of antipsychotic drugs among older individuals with dementia. These drugs are not approved for such use and both the Food and Drug Administration and European Medicines Agency have issued warnings to limit such use.
JAMDA
February 25, 2016
Curtailing Antipsychotic Use in LTC Medicine: Reducing Off-Label Antipsychotic Medication Use Among Maine Skilled Nursing Centers with the CALM Intervention
JAMDA
September 24, 2016
Perceptions of Gown and Glove Use to Prevent Methicillin-resistant Transmission in Nursing HomesStaphylococcus aureusPerceptions of Gown and Glove Use to Prevent Methicillin-resistant Transmission in Nursing Homes
To explore current use and perceptions of glove and gown use in nursing homes.
JAMDA
August 14, 2014
Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study
To determine factors associated with the antipsychotic (AP) prescription for people with dementia (PwD) recently admitted to institutional long-term care facilities (LTCFs) and to ascertain differences in the use of this medication in 8 European countries.
JAMDA
January 28, 2021
Cognition-Enhancing, Antipsychotic, and Opioid Medication Use Among Assisted Living and Residential Care Residents in Oregon
Explore community- and resident-level characteristics associated with polypharmacy and use of cognition-enhancing, antipsychotic, and opioid medications among a statewide representative sample of assisted living and residential care (AL/RC) residents.
JAMDA
June 8, 2024
Prevalence and Correlates of Antipsychotic Medication Use in Oregon Assisted Living
Investigate how assisted living and residential care (AL/RC) and memory care (MC) contexts are associated with the 90-day prevalence of antipsychotic medication use (APU), considered a quality measure in long-term care.
JAMDA
June 22, 2018